Company Filing History:
Years Active: 2013-2014
Title: The Innovative Contributions of Cara L Ferreira
Introduction
Cara L Ferreira is a notable inventor based in Surrey, Canada. She has made significant contributions to the field of chelating agents, with a focus on developing innovative solutions for pharmaceutical applications. Her work has led to the creation of two patents that showcase her expertise and dedication to advancing medical science.
Latest Patents
Cara L Ferreira holds two patents that highlight her innovative approach to chelating agents. The first patent is for "Bifunctional Chelating Agents," which describes a bifunctional chelating agent of a specific formula. This patent also details a complex of the chelating agent with an ion of a stable or radioactive metal, a conjugate of the complex covalently attached to a biological carrier, and a pharmaceutical composition containing the conjugate. The second patent, "Bifunctional Polyazamacrocyclic Chelating Agents," outlines a similar approach, focusing on a bifunctional polyazamacrocyclic chelating agent. This patent describes a complex of the chelating agent with a metal ion, a conjugate attached to a biological carrier, and a method for therapeutic treatment involving the pharmaceutical composition.
Career Highlights
Cara L Ferreira is currently employed at Nordion (Canada) Inc., where she continues to develop her innovative ideas and contribute to the field of medical technology. Her work at Nordion has positioned her as a key player in the development of advanced pharmaceutical solutions.
Collaborations
Throughout her career, Cara has collaborated with talented individuals such as Mike Adam and Eszter Boros. These collaborations have allowed her to enhance her research and expand the impact of her inventions.
Conclusion
Cara L Ferreira's contributions to the field of chelating agents demonstrate her commitment to innovation and medical advancement. Her patents reflect her expertise and the potential for her work to improve therapeutic treatments.